Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2018 Dec 8;7(5):1671–1672.e3. doi: 10.1016/j.jaip.2018.11.034

Table 2:

Comparative Clinic Characteristics of patients with and without Hearing Loss and MES

MES No MES p-value Hearing Loss No Hearing
Loss
p-value Loss
Age 48.1 ± 0.7 46.2 ± 0.7 .06 51.0 ± 1.0 44.8 ± 0.6 <0.0001
Age at Onset of Asthma 28.2 ± 0.8 30.6 ± 0.8 <0.05 28.6 ± 1.1 28.9 ± 0.7 .74
Age at Onset of NP 40.2 ± 0.7 35.0 ± 0.7 .41 33.9 ± 1.0 34.3 ± 0.6 .73
Duration of NP 14.5 ± 0.6 11.17 ± 0.5 <0.0001 17.2 ± 0.9 10.3 ± 0.4 <0.0001

MES – middle ear symptoms. NP – nasal polyps. Ages and duration of NP are reported as mean years +/− standard error